{"id":"https://openalex.org/W2340579271","doi":null,"title":"Biphasic Adrenergic Modulation of f8-Adrenergic Receptors in Man AGONIST-INDUCED EARLY INCREMENT AND LATE DECREMENT","display_name":"Biphasic Adrenergic Modulation of f8-Adrenergic Receptors in Man AGONIST-INDUCED EARLY INCREMENT AND LATE DECREMENT","alternate_titles":[],"publication_year":1980,"publication_date":"1980-01-01","ids":{"openalex":"https://openalex.org/W2340579271","mag":"2340579271"},"language":"en","primary_location":{"id":"mag:2340579271","doi":null,"is_oa":false,"landing_page_url":"https://dm5migu4zj3pb.cloudfront.net/manuscripts/109000/109735/JCI80109735.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2340579271"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108624170","display_name":"Philip E. Cryer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Philip E. Cryer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5108624170"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/beta-adrenergic-receptors","display_name":"beta-adrenergic receptors","score":0.9010000228881836},{"id":"https://openalex.org/keywords/isoproterenol","display_name":"isoproterenol","score":0.8299999833106995},{"id":"https://openalex.org/keywords/epinephrine","display_name":"epinephrine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dihydroalprenolol-binding","display_name":"dihydroalprenolol binding","score":0.8880000114440918},{"id":"https://openalex.org/keywords/mononuclear-leukocytes","display_name":"mononuclear leukocytes","score":0.9340000152587891},{"id":"https://openalex.org/keywords/circulating-leukocytes","display_name":"circulating leukocytes","score":0.5149999856948853},{"id":"https://openalex.org/keywords/research-participants","display_name":"research participants","score":0.37299999594688416}],"concepts":[{"id":"https://openalex.org/C2778438532","wikidata":"https://www.wikidata.org/wiki/Q5276415","display_name":"Dihydroalprenolol","level":5,"score":0.9400187730789185},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7618191242218018},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7516632676124573},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6938756108283997},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.6736060976982117},{"id":"https://openalex.org/C158453852","wikidata":"https://www.wikidata.org/wiki/Q4684738","display_name":"Adrenergic","level":3,"score":0.5626987218856812},{"id":"https://openalex.org/C40465926","wikidata":"https://www.wikidata.org/wiki/Q410568","display_name":"Adrenergic receptor","level":3,"score":0.5428597331047058},{"id":"https://openalex.org/C2908653273","wikidata":"https://www.wikidata.org/wiki/Q598405","display_name":"Adrenergic Agent","level":4,"score":0.5211015939712524},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.49767544865608215},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4919833838939667},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.4875637888908386},{"id":"https://openalex.org/C2780275434","wikidata":"https://www.wikidata.org/wiki/Q201370","display_name":"Alprenolol","level":3,"score":0.41762495040893555},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.30634260177612305},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.2443411946296692},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.1678861379623413},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.15779995918273926},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13034343719482422}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2340579271","doi":null,"is_oa":false,"landing_page_url":"https://dm5migu4zj3pb.cloudfront.net/manuscripts/109000/109735/JCI80109735.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1544485440","https://openalex.org/W1775749144","https://openalex.org/W1969866157","https://openalex.org/W1975353340","https://openalex.org/W1982244798","https://openalex.org/W1997342108","https://openalex.org/W2001954238","https://openalex.org/W2008568685","https://openalex.org/W2015335242","https://openalex.org/W2052062999","https://openalex.org/W2087206511","https://openalex.org/W2094189881","https://openalex.org/W2133884882","https://openalex.org/W2145394737","https://openalex.org/W2155502587","https://openalex.org/W2162027734","https://openalex.org/W2221697229","https://openalex.org/W2468119228"],"related_works":["https://openalex.org/W2151556344","https://openalex.org/W2059106680","https://openalex.org/W2103923504","https://openalex.org/W2056237088","https://openalex.org/W2001668716","https://openalex.org/W2054742110","https://openalex.org/W1993508801","https://openalex.org/W2188020337","https://openalex.org/W2294288639","https://openalex.org/W1499650759"],"abstract_inverted_index":{"A":[0],"B":[1,148],"S":[2],"T":[3,6,146],"RA":[4],"C":[5],",3-Adrenergic":[7],"receptors":[8,165],"in":[9,111,121,127,139,145,170,182,190,193,217,228],"mononuclear":[10,141,168],"leukocyte":[11],"preparations":[12],"were":[13,107,134],"assessed":[14],"with":[15,174],"(-)[H]dihydroalprenolol":[16],"binding":[17,40,87,116,122,132],"studies":[18],"during":[19],"the":[20,30,79,112,128,160,185,188,212],"infusion":[21,31,80,198,209],"of":[22,32,114,130,162,199,207],"adrenergic":[23,157],"agonists":[24,158],"into":[25,34,82],"normal":[26],"human":[27],"subjects.":[28],"During":[29,78],"isoproterenol":[33,200],"seven":[35],"subjects,":[36,84],"mean":[37,85],"(\u00b1SE)":[38],"(-)WH]dihydroalprenolol":[39],"increased":[41,88],"from":[42,89],"25\u00b13":[43],"fmol/mg":[44,48,58,70,93],"protein":[45,49,59,71,94],"to":[46,68,91,109,195],"47\u00b18":[47],"(P":[50,60,72,95],"<":[51,61,73,96],"0.02)":[52],"at":[53,63,75,98],"0.5":[54],"h":[55,65,206],"and":[56,66,150,178],"40\u00b13":[57],"0.01)":[62,74,97],"1":[64],"decreased":[67],"12\u00b11":[69],"4-6":[76],"h.":[77,100],"ofepinephrine":[81],"three":[83],"(-)pH]dihydroalprenolol":[86,131],"32\u00b13":[90],"63\u00b13":[92],"0.5-1":[99,205],"By":[101],"Scatchard":[102],"plot":[103],"analysis,":[104],"these":[105],"changes":[106,110,120,126,138],"attributable":[108],"number":[113,129,161,220],"available":[115,163],"sites":[117,133],"rather":[118],"than":[119],"affinity.":[123],"The":[124],"observed":[125,213],"not":[135],"paralleled":[136,225],"by":[137,226],"total":[140],"cell":[142],"counts":[143],"or":[144],"lymphocyte,":[147,149],"monocyte":[151],"distributions.":[152],"Thus,":[153],"we":[154],"conclude":[155],"that":[156,187,211],"modulate":[159],"f8-adrenergic":[164],"on":[166,221],"circulating":[167,222],"cells":[169,223],"a":[171,179,196],"biphasic":[172],"manner,":[173],"an":[175],"early":[176,214],"increment":[177,216],"late":[180],"decrement,":[181],"man.":[183],"Further,":[184],"finding":[186],"increase":[189],"pulse":[197],"rate":[192],"response":[194],"was":[201],"significantly":[202],"greater":[203],"after":[204],"agonist":[208],"suggests":[210],"agonist-induced":[215],"f3-adrenergic":[218],"receptor":[219,231],"is":[224],"increments":[227],"extra-vascular,":[229],"-adrenergic":[230],"sensitivity.":[232]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2340579271","counts_by_year":[],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
